Innovative mRNA Vaccine Approaches in Targeting Atherosclerosis
Author Information
Author(s): Muacevic Alexander, Adler John R, Kumar Rahul, Krishnaperumal Gowri, Vellapandian Chitra
Primary Institution: SRM Institute of Science and Technology
Hypothesis
Can mRNA vaccines effectively target the mechanisms of atherosclerosis to improve cardiovascular therapy?
Conclusion
mRNA vaccines have the potential to provide more effective and personalized treatments for atherosclerosis by targeting inflammation and lipid metabolism.
Supporting Evidence
- Atherosclerosis is a major cause of cardiovascular disease, driven by inflammation and lipid metabolism disturbances.
- Current therapies often fall short due to patient non-compliance and residual risks.
- mRNA vaccines could produce therapeutic proteins to modulate inflammation and stabilize plaques.
Takeaway
This study looks at how new mRNA vaccines could help treat heart disease by fixing problems in the blood vessels and cholesterol levels.
Methodology
This is a review article exploring emerging mRNA vaccine strategies for atherosclerosis.
Limitations
Challenges include replicating human atherosclerosis in models, regulatory concerns about long-term safety, and ensuring accessibility in low-resource settings.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website